Explores the history, mechanisms, and players of cancer immunotherapies, including immune evasion strategies and the role of MHC in antigen presentation.
Covers enzyme inhibition mechanisms, drug modes of action, targeted protein degradation using PROTACs, and the bump-hole method for protein-ligand engineering.
Explains cellular uptake mechanisms, focusing on phagocytosis, pinocytosis, and receptor-mediated endocytosis, highlighting the importance of size and shape in these processes.
Explores the activation and differentiation of T lymphocytes, focusing on naive T cells recognizing antigens and differentiating into effector and memory cells.
